Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD)
Clinical trial NCT03852719 · COMPLETED
Trial details
- NCT number
- NCT03852719
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-17
- Primary completion
- 2020-11-26
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.